[1] DIXON S, LEMBERG K, LAMPRECHT M, et al. Ferroptosis:an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5):1060-1072.
[2] XIE Y, HOU W, SONG X, et al. Ferroptosis:process and function[J]. Cell Death Differ, 2016, 23(3):369-379.
[3] CHEN L, LI X, LIU L, et al. Erastin sensitizes glioblastoma cells to temozolomide byrestraining xCT and cystathionine-γ-lyase function[J]. Oncol Rep, 2015, 33(3):1465-1474.
[4] LE J, NING K, LE T, et al. Ferroptosis as a P53-mediated activity during tumour suppression[J]. Nature, 2015, 520(7545):57-62.
[5] SHIMADA K, HAYANO M, PAGANO N, et al. Cell-line selectivity improves the predictive power of pharmacogenomic analyses and helps identify NADPH as biomarker for ferroptosis sensitivity[J]. Cell Chem Biol, 2016, 23(2):225-235.
[6] GAO M, MONIAN P, QUADRI N, et al. Glutaminolysis and transferrin regulate ferroptosis[J]. Molecular Cell, 2015, 9(2):298-308.
[7] GAO M, MONIAN P, JIANG X, et al. Metabolism and iron signaling in ferroptotic cell death[J]. Oncotarget, 2015, 6(34):35145-35146.
[8] GAMMELLA E, RECALCATI S, RYBINSKA I, et al. Iron-induced damage in cardiomyopathy:oxidative-dependent and independent mechanisms[J]. Oxid Med Cell Long, 2015, 10(2):1-10.
[9] WAN S Y, STOCKWELL B R. Ferroptosis:death by lipid peroxidation[J]. Trends Cell Biol, 2015, 26(3):165-176.
[10] RAN Q T, CHEN L J, HAMBRIGHT W S, et al. Ablation of Gpx4 in neurons results in rapid motor neuron degeneration and paralysis[J]. Free Rad Biol Med, 2015, 87:34-34.
[11] KABIRAJ P, VALENZUELA C A, MARIN J E, et al. The neuroprotective role of ferrostatin-1 under rotenone-induced oxidative stress in dopaminergic neuroblastoma cell [J]. Protein J, 2015, 34(5):349-358.
[12] HOFMANS S, BERGHE T V, DEVISSCHER L, et al. Novel ferroptosis inhibitors with improved potency and ADME properties[J]. J Med Chem, 2016, 59(5):2041-2053.
[13] KANG Y, TIZIANI S, PARK G, et al. Cellular protection using Flt3 and PI3K inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity[J]. Nat Commun, 2014, 5(1):277-287.
[14] LIU Y, WANG W, LI Y, et al. The 5-lipoxygenase inhibitor zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis[J]. Biol Pharm Bull, 2015, 38(8):1234-1239.
[15] MAI M, STEFAN F, CHRISTOPH S, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection[J]. J Exp Med, 2015, 212(4):51-57.
[16] TORII S, SHINTOKU R, KUBOTA C, et al. An essential role for functional lysosomes in ferroptosis of cancer cells[J]. Biochem J, 2016, 473(6):769-777.
[17] XIE Y, SONG X, SUN X, et al. Identification of baicalein as a ferroptosis inhibitorby natural product library screening[J]. Biochem Biophys Res Commun, 2016, 473(4):775-780.
[18] NICHOLAS Y, MORITZ V R, ELMA Z, et al. RAS-RAF-MEK-dependent oxidative cell deathinvolving voltage-dependent anion channels[J]. Nature, 2007, 447(7146):864-865.
[19] KWON M Y, PARK E, LEE S J, et al. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death[J]. Oncotarget, 2015, 6(27):24393-24403.
[20] YANG W S, SRIRAMARATNAM R, WELSCH M, et al. Regulation of ferroptotic cancer cell deathby GPX4[J]. Cell, 2014, 156(1-2):317-331.
[21] LARRAUFIE M H, WAN S Y, JIANG E, et al. Incorporation of metabolically stableketonesintoa small molecule probe to increase potency and water solubility[J]. Bioorg Med Chem Lett, 2015, 25(21):4787-4792.
[22] GALMICHE A, CHAUFFERT B, BARBARE J C, et al. New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma[J]. Cancer Lett, 2014, 346(2):159-162.
[23] CHEN L, NA R, GU M, et al. Lipid peroxidation up-regulates BACE1 expression in vivo:a possible early event of amyloidogenesis in Alzheimer's disease[J]. Human Molecular Genetics, 2008, 107(1):197-207.
[24] SHIMADA, SKOUTA R, KAPLAN A, et al. Global survey of cell death mechanismsrevealsmetabolic regulation of ferroptosis[J]. Nat Chem Biol, 2016, 12(7):497-503.
[25] MA S, HENSON E S, CHEN Y, et al. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells[J]. Cell Death Dis, 2016, 7(7):e2307
[26] GUO J P. Cisplatin induces ferroptosis in cancer cells and its mechanism[D]. Wuhan:Huazhong University of Science and Technology, 2014.
[27] LINCZ T, JEMNITZ K, KARDON T, et al. Ferroptosis is involved in acetaminophen Induced cell death[J]. Pathol Oncol Res, 2015, 21(4):1115-1121.
[28] ELING N, REUTER L, HAZIN J, et al. Identification of artesunate as a specific activator offerroptosis in pancreatic cancer cells[J]. Oncoscience, 2015, 2(5):517-532.
[29] OOKO E, SAEED M E, KADIOGLU O, et al. Artemisinin derivatives induce iron-dependentcell death (ferroptosis) in tumor cells[J]. Phytomed Int J Phytother Phytopharmacol, 2015, 22(11):1045-1054.
[30] VAN B D, GOUEL F, JONNEAUX A, et al. Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC[J]. Neurobiol Dis, 2016, 94:169-178.
[31] BOGDAN A R, MIYAZAWA M, HASHIMOTO K, et al. Regulators of iron homeostasis:new players in metabolism cell, death and disease[J]. Trends Biochem Sci, 2016, 41(3):274-286.
[32] GASCN S, MURENU E, MASSERDOTTI G, et al. Identification and successful negotiation of a metabolic check point in direct neuronal reprogramming[J]. Cell Stem Cell, 2016, 18(3):396-409.
[33] YU Y, XIE Y, CAO L, et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents[J]. Molecul Cell Oncol, 2015, 2(4):e1054549.
[34] HASEGAWA M, TAKAHASHI H, RAJABI H, et al. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells[J]. Oncotarget, 2016, 7(11):11756-11769.
[35] GOUT P W, BUCKLEY A R, SIMMS C R, et al. Sulfasalazine, a potent suppressorof lymphomagrowth by inhibition of the x(c)-cystine transporter:a new action for an old drug[J]. Leukemia, 2001, 15(10):1633-1640.
[36] LIU R Y, ZHANG Z H, CHEN L F, et al. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells[J]. Cancer Lett, 2016, 381(1):165-175.
[37] LOUANDRE C, MARCQ I, BOUHLAL H, et al. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells[J]. Cancer Lett, 2015, 356(2):971-977.
[38] HUAIMIN L, XIN W, GUIRONG S, et al. Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo[J]. Tumour Biol J Int Soc Oncodevelop Biol Med, 2014, 35(8):8249-8258.
[39] CONRAD M, ANGELI J P F, VANDENABEELE P, et al. Regulated necrosis:disease relevance and therapeutic opportunities[J]. Nat Rev Drug Discov, 2016, 15(5):348-366.
[40] WU D, CHEN L. Ferroptosis:a novel cell death form will be a promising therapy target for diseases[J]. Acta Biochim Biophys Sin, 2015, 47(10):857-859.
[41] TELORACK M, MEYER M, INGOLD I, et al. A glutathione-Nrf2-thioredoxin cross-talk ensures keratinocyte survival and efficient wound repair[J]. PLoS Genet, 2016, 12(1):e1005800.
[42] IGLEHART J K, YORK R M, MODEST A P, et al. Cystine requirement of continuous human lymphoid cell lines of normal and leukemic origin[J]. J Biol Chem, 1977, 252(20):7184-7191.
[43] HAYANO M, YANG W S, CORN C K, et al. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation[J]. Cell Death Differ, 2015, 23(2):270-278.
[44] MCBEAN G J. The transsulfuration pathway:a source of cysteine for glutathione in astrocytes[J]. Amino Acids, 2012, 42(1):199-205.
[45] KRYUKOV G V, SERGI C, NOVOSELOV S V, et al. Characterization of mammalian selenoproteomes[J]. Science, 2003, 300(5624):1439-1443.